Rare:
Rare: is a London-based healthcare commercial intelligence firm whose Rare.Monitor SaaS platform provides pharmaceutical and medical device sales teams with daily-refreshed prospect, account, and market data across 160,000+ UK and Ireland healthcare providers, serving enterprise customers such as L'Oreal, Novo Nordisk, and Galderma.
- Company typePrivate
- Founded2014
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Rare: does
Rare: (legally Rare: Training & Consultancy) is a UK-based healthcare commercial intelligence company serving pharmaceutical and medical device sales teams. Founded in 2014 and headquartered at 45 Holmes Rd, London, the firm operates with 11-50 employees as a privately held limited partnership registered in England and Wales. Its core offering is Rare.Monitor, a SaaS platform that aggregates daily-refreshed data on over 160,000 UK and Ireland healthcare providers and unifies prospect identification, account management, CRM activity logging, territory mapping, training course management, and brand amplification analytics within a single workflow. The platform is supplemented by a structured Rare.Monitor Training Guide providing video onboarding across core workflows, and is positioned against generic CRMs and research subscriptions as a purpose-built commercial intelligence layer for private healthcare.
The firm operates an enterprise sales-led go-to-market with demo-based qualification and pricing not publicly disclosed, reflecting an annual subscription model. Named customers include multinational pharmaceutical and medical device companies such as L'Oreal, Novo Nordisk, Galderma, Daiichi Sankyo UK, Establishment Labs, Professional Dietetics (SUNEKOS), Align Technology, and Alma, alongside healthcare providers NHS and The London Clinic. The company is a member of MRS, ABPI, and BHBIA, holds ICO registration ZA103245, and is privately held with no external funding rounds disclosed. Beyond Rare.Monitor, the firm publishes a regular cadence of brand amplification and market statistics reports covering UK and ROI sectors including medical aesthetics, medical-grade skincare, dermal fillers, dental, ophthalmology, audiology, MSK, and obesity treatments, functioning as a continuous content-marketing engine for its core SaaS offering.
Rare: firmographics
Firmographics- Name
- Rare:
- Legal name
- Rare: Training & Consultancy
- Website
- https://rare.consulting
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Rare: is a London-based healthcare commercial intelligence firm whose Rare.Monitor SaaS platform provides pharmaceutical and medical device sales teams with daily-refreshed prospect, account, and market data across 160,000+ UK and Ireland healthcare providers, serving enterprise customers such as L'Oreal, Novo Nordisk, and Galderma.
- Ownership category
- akta.pro rank
Rare: industry classification
Industry- Product category
- Healthcare Commercial Intelligence Software
- NAICS
- Marketing Research and Public Opinion Polling (541910), Software Publishers (513210)
- akta.pro primary industry
- Public Relations Measurement, Analytics & Monitoring (BPAFADAL)
Keywords
Where Rare: is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Rare: business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Rare.Monitor SaaS Subscription: Subscription-based commercial intelligence platform for pharmaceutical and medical device sales teams, providing market data, prospect targeting, and account management capabilities on a recurring subscription model
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise subscription for commercial teams |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Rare: product offering
Product offeringCore offering
Rare: sells Rare.Monitor, a SaaS commercial intelligence platform that gives pharmaceutical and medical device sales teams one place to find prospects, manage accounts, and track performance across 160,000+ UK and Ireland healthcare providers. The platform combines live market intelligence, CRM functionality, territory mapping, training course management, and brand amplification analytics, delivered as a recurring enterprise subscription and complemented by structured training content and periodic market research publications.
Product overview
Rare: operates as a healthcare commercial intelligence company with a unified platform-and-training model. The core product is Rare.Monitor, a SaaS platform providing prospect identification, account management, CRM functionality, and live market intelligence across 160,000+ UK and Ireland healthcare providers. The platform is complemented by a structured training guide featuring video lessons covering all core workflows from prospect discovery to CRM recording. Rare: also produces regular brand amplification reports and market statistics publications analyzing UK private healthcare sectors including medical aesthetics, dermatology, MSK, ophthalmology, dentistry, audiology, and obesity treatments.
Differentiator
Problem solved
Functional benefit
Brands
- Rare.Monitor: Commercial platform for healthcare providing prospect targeting, account management, and market intelligence for pharmaceutical and medical device sales teams across UK and Ireland healthcare providers.
Products and services
- Rare.Monitor A commercial intelligence SaaS platform for pharmaceutical and medical device sales teams, providing prospect identification, account management, CRM functionality, territory mapping, training course management, and live market intelligence across over 160,000 UK and Ireland healthcare providers with daily data refresh.
- Rare.Monitor Training Guide Step-by-step video lessons covering Rare.Monitor usage from first login to CRM activity recording, including Getting Started, Using Filters, Territory Building & Mapping, Creating and Managing Lists, Regional Analysis, Training Courses, and CRM Records management, designed to onboard pharmaceutical and medical device commercial teams.
Quantifiable outcome
- +106% increase in prospect engagement
- +3 more outcomes
Companies that use Rare:
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles2 records
Rare: technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Rare: partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights6 records
Rare: competitors and assessment
Company assessmentBroad incumbents
- Veeva Systems: Veeva is the dominant pharma CRM and commercial cloud platform (Veeva CRM, Veeva Vault). While global in scope and far larger than Rare, it competes for the same pharma/medtech commercial-team wallet and represents the most likely large-platform encroachment risk in Rare's category.
- IQVIA: IQVIA is the largest healthcare data, analytics, and commercial intelligence incumbent globally, with deep UK presence. It sells overlapping market intelligence, sales targeting, and analytics to pharma/medtech customers and is the primary broad-based competitor to Rare's commercial intelligence proposition.
- ZS Associates: ZS is a major pharma sales-and-marketing consulting and analytics firm with technology products for sales force targeting and incentive design. It competes with Rare for the same pharma commercial intelligence and targeting budget, often with a more consulting-led delivery model.
- Clarivate (DRG): Clarivate, including the former Decision Resources Group, is a major healthcare market research and commercial intelligence provider. Its disease-level and brand-level market research overlaps with Rare's brand amplification and market stats publications for life-sciences clients.
Regional players
- Cogora: Cogora is a UK healthcare media, market research, and intelligence provider serving pharma and medical device clients. It overlaps with Rare's content, insights, and market research offerings for the same UK healthcare customer base.
- Creation Healthcare: Creation Healthcare provides UK healthcare professional insights and market intelligence, including HCP social media and digital behavior analytics. It is a regional UK peer with comparable pharmaceutical/medtech customer use cases around HCP engagement and brand tracking.
- Wilmington Healthcare: Wilmington Healthcare is a UK-focused healthcare market intelligence and data provider serving pharma and the NHS. It is a direct UK regional peer to Rare with overlapping NHS/private provider analytics and similar pharma customer base.
Emerging players
- Komodo Health: Komodo Health provides US-focused healthcare data and analytics for life-sciences commercial teams using a large linked provider/patient dataset. It is an emerging player in the same healthcare commercial intelligence category as Rare, differentiated by its scale and patient-level analytics.
Direct peers
- Cegedim: Cegedim offers healthcare CRM, provider databases, and life-sciences commercial intelligence across Europe, including UK. It is one of the most direct competitors to Rare's combined CRM + provider-data positioning for European pharma/medtech sales teams.
- Definitive Healthcare: Definitive Healthcare provides healthcare commercial intelligence and provider analytics to life-sciences companies in the US. It is a direct functional peer in the 'provider-level commercial intelligence for life sciences' category, though US-focused versus Rare's UK/Ireland focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Rare: social profiles
Digital presenceRare: compliance and trust
Trust signalCompliance4 records
Rare: financial estimates
Financial estimateRevenue estimate
Valuation estimate
Rare: leadership team
Management profileNumber of profiles
Profiles1 record
Rare: funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Rare: M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Rare:
What does Rare: do?
Rare: sells Rare.Monitor, a SaaS commercial intelligence platform that gives pharmaceutical and medical device sales teams one place to find prospects, manage accounts, and track performance across 160,000+ UK and Ireland healthcare providers. The platform combines live market intelligence, CRM functionality, territory mapping, training course management, and brand amplification analytics, delivered as a recurring enterprise subscription and complemented by structured training content and periodic market research publications.
Is Rare: a public or private company?
Rare: is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Rare: founded?
Rare: was founded in 2014. It employs 11 to 50 people.
Where is Rare: based?
Rare: is headquartered in London, United Kingdom, in the Europe region.
How does Rare: make money?
One revenue line is on record: rare.Monitor SaaS Subscription.
Who are Rare:'s main competitors?
Broad incumbents on record are Veeva Systems, IQVIA, ZS Associates and Clarivate (DRG). Regional players are Cogora, Creation Healthcare and Wilmington Healthcare. Komodo Health is listed as an emerging player. Direct peers are Cegedim and Definitive Healthcare.
Does Rare: have an API?
No public API is recorded for Rare:.
What industry is Rare: in?
Rare:'s product category is Healthcare Commercial Intelligence Software. Its primary akta.pro industry code is BPAFADAL, Public Relations Measurement, Analytics & Monitoring. Its NAICS code is 541910.